Menopausal women turn to Wegovy, Ozempic for weight loss
Women going through menopause are increasingly turning to Ozempic, Wegovy, Mounjaro and other glucagon-like peptide-1 receptor agonists to lose weight — but physicians are raising concerns about side effects and unknown long-term results.